Return On Equity of NewAmsterdam Pharma Co N.V. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NewAmsterdam Pharma Co N.V. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • NewAmsterdam Pharma Co N.V. Return On Equity for the quarter ending 31 Dec 2025 was -27%, a 45% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Return On Equity for 2025 was -27%, a 45% increase from 2024.
  • NewAmsterdam Pharma Co N.V. annual Return On Equity for 2024 was -50%, a 1.8% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NewAmsterdam Pharma Co N.V. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -27% +22% +45% 01 Oct 2025 31 Dec 2025
Q3 2025 -29% +25% +46% 01 Jul 2025 30 Sep 2025
Q2 2025 -25% +40% +62% 01 Apr 2025 30 Jun 2025
Q1 2025 -33% +33% +50% 01 Jan 2025 31 Mar 2025
Q4 2024 -50% +0.92% +1.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -54% 01 Jul 2024 30 Sep 2024
Q2 2024 -65% 01 Apr 2024 30 Jun 2024
Q1 2024 -65% 01 Jan 2024 31 Mar 2024
Q4 2023 -51% 01 Oct 2023 31 Dec 2023

NewAmsterdam Pharma Co N.V. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -27% +22% +45% 01 Jan 2025 31 Dec 2025
2024 -50% +0.92% +1.8% 01 Jan 2024 31 Dec 2024
2023 -51% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.